The post Strategy Buys 1,031 BTC, Launches $42B Capital Plan for Bitcoin appeared on BitcoinEthereumNews.com. Strategy purchased 1,031 BTC, approximately $76.6The post Strategy Buys 1,031 BTC, Launches $42B Capital Plan for Bitcoin appeared on BitcoinEthereumNews.com. Strategy purchased 1,031 BTC, approximately $76.6

Strategy Buys 1,031 BTC, Launches $42B Capital Plan for Bitcoin

2026/03/24 18:34
Okuma süresi: 3 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen crypto.news@mexc.com üzerinden bizimle iletişime geçin.
  • Strategy purchased 1,031 BTC, approximately $76.6 million.
  • Strategy announced new $21 billion ATM programs for MSTR and STR.
  • A March 23 Form 8-K added new sales agents and updated share terms.

Strategy ( formerly known as MicroStrategy) expanded its Bitcoin holdings while introducing a major capital plan. The company purchased 1,031 BTC and launched new ATM programs worth up to $42 billion. The move increases funding flexibility as the firm continues its Bitcoin accumulation strategy.

Strategy Buys 1,031 Bitcoin

In a recent tweet post on X, Strategy confirmed that it acquired 1,031 BTC for about $76.6 million at roughly $74,326 per bitcoin. However, the Strategy acquired this additional bitcoin on March 22, 2026. 

Following the latest buy, Strategy’s total holdings increased to 762,099 BTC, acquired for around $57.69 billion at an average price of $75,694 per Bitcoin.

The purchase shows that Strategy continues adding Bitcoin near its average acquisition cost, reinforcing its long-term treasury strategy.

Strategy $21 Billion ATM Programs For MSTR and STRC

Strategy also announced new at-the-market (ATM) programs to raise capital. The company introduced $21 billion for MSTR and $21 billion for STRC, bringing total potential funding to $42 billion.

These programs provide flexible capital access that may support future Bitcoin purchases. Market participants closely monitor such funding tools, as they influence liquidity and share supply.

The new capacity expands Strategy’s ability to raise funds while continuing its accumulation approach.

Form 8-K Introduces Agents, Provides Details, and Shares Changes

Furthermore, an additional detail was given by a Form 8-K dated March 23, 2026. Strategy displayed Moelis and Company, A.G.P./Alliance Global Partners, and StoneX Financial as new sales agents in its Omnibus Sales Agreement. 

Prospectus supplements have been registered for up to $21.0 billion of common stock, $21.0 billion of STRC preferred stock, and up to 2.1 billion of STRK preferred stock.

Source: Strategy

The filing detail also showed a change in authorized shares. STRC shares increased from 70,435,353 to 282,556,565, while STRK shares fell from 269,800,000 to 40,270,744. Those adjustments show how Strategy is reshaping its funding mix while still adding bitcoin.

Disclaimer: The information presented in this article is for informational and educational purposes only. The article does not constitute financial advice or advice of any kind. Coin Edition is not responsible for any losses incurred as a result of the utilization of content, products, or services mentioned. Readers are advised to exercise caution before taking any action related to the company.

Source: https://coinedition.com/strategy-buys-1031-btc-launches-42b-capital-plan-for-bitcoin/

Piyasa Fırsatı
Ucan fix life in1day Logosu
Ucan fix life in1day Fiyatı(1)
$0.0004771
$0.0004771$0.0004771
+13.46%
USD
Ucan fix life in1day (1) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen crypto.news@mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.